šŸ’° Financial Performance

Revenue Growth by Segment

Mother and Child Care services grew 26% YoY in Q2 FY26. Total revenue from operations for Q2 FY26 reached INR 74.9 Cr, representing a 33.2% increase from INR 56.2 Cr in Q2 FY25. Annual revenue for FY25 grew 30.7% to INR 231.6 Cr from INR 177.2 Cr in FY24.

Geographic Revenue Split

100% of the entity's operations are situated in Trichy, Tamil Nadu, across two hospital blocks. The parent group serves a broader market across Chennai, Trichy, Bengaluru, Salem, Hosur, and Tirunelveli.

Profitability Margins

Net Profit Margin (PAT) for Q2 FY26 was 14.0%, more than doubling from 6.9% in Q2 FY25. Profit Before Tax (PBT) margin improved significantly to 19.4% from 9.4% YoY, driven by higher volumes and a better revenue mix.

EBITDA Margin

EBITDA margin for Q2 FY26 was 29%, a substantial increase from 22.9% in Q2 FY25. Total EBITDA earned increased by INR 9.1 Cr, representing 70% YoY growth.

Capital Expenditure

Net cash used in investing activities was INR 50.94 Cr in FY25, a significant increase from INR 4.45 Cr in FY24, primarily reflecting the investment in operationalizing the new 200-bed hospital block.

Credit Rating & Borrowing

Not disclosed in available documents; however, the company reported a net cash outflow from financing activities of INR 2.30 Cr in FY25.

āš™ļø Operational Drivers

Raw Materials

Medical consumables, pharmaceuticals, and surgical supplies. While specific % of total cost is not disclosed, 'Supply chain management' is identified as a material issue for business continuity.

Capacity Expansion

Current installed capacity is 450 beds, comprising a 250-bed legacy block and a newly operationalized 200-bed block focused on Mother & Child care.

Raw Material Costs

Not disclosed as a specific percentage of revenue, but the company identifies the availability of raw materials and supplies as a material risk to operations.

Manufacturing Efficiency

Efficiency is maintained through the 5S Model Hospital Certification and NABH standards. The expansion of EBITDA margins to 29% indicates high operational efficiency in the new 200-bed facility.

Logistics & Distribution

Not applicable as a healthcare service provider; patients visit the hospital locations directly.

šŸ“ˆ Strategic Growth

Expected Growth Rate

22%

Growth Strategy

Growth is driven by the operationalization of the new 200-bed Mother & Child care block and the expansion of high-end specialty programs including Neuro Science and Transplants (85+ Bone Marrow and 42+ Liver transplants completed). The company leverages its 25-year group legacy to increase patient volumes.

Products & Services

Tertiary healthcare services including Mother and Child care, Paediatrics, Neuro Science, and Organ Transplant programs (Liver and Bone Marrow).

Brand Portfolio

Kauvery Hospital, KMC Speciality Hospitals.

New Products/Services

The new Mother & Child care services segment contributed to a 26% growth in its specific revenue stream during Q2 FY26.

Market Expansion

Expansion is focused on the Trichy region through the new 200-bed block, while the parent group expands its footprint across South India.

Strategic Alliances

The company is a 75% subsidiary of Sri Kauvery Medical Care (India) Limited, benefiting from group-level procurement and branding.

šŸŒ External Factors

Industry Trends

The healthcare industry is shifting toward specialized tertiary care and accredited hospital chains. KMC is positioned to capture this through its NABH-certified facilities and 22% historical CAGR.

Competitive Landscape

Competes with other multi-specialty hospital chains in South India, distinguishing itself through specialized Mother & Child and transplant services.

Competitive Moat

Sustainable advantages include NABH and ISO 27001:2022 certifications, a 25-year brand legacy, and high entry barriers for specialized transplant programs.

Macro Economic Sensitivity

Highly sensitive to healthcare spending trends and insurance penetration in the Tamil Nadu region.

Consumer Behavior

Increasing consumer preference for accredited (NABH) hospitals and specialized centers for complex medical procedures.

Geopolitical Risks

Low, as operations are entirely domestic and concentrated in South India.

āš–ļø Regulatory & Governance

Industry Regulations

Strict adherence to NABH healthcare guidelines, ISO 27001:2022 for information security, and Fire safety standards.

Environmental Compliance

Conducts regular ESG and Bio-Medical Waste (BMW) audits to ensure compliance with environmental norms.

Taxation Policy Impact

The company's effective tax impact is reflected in the margin gap between PBT (19.4%) and PAT (14.0%) for Q2 FY26.

Legal Contingencies

Zero complaints filed regarding bribery or corruption. Zero complaints pending regarding sexual harassment at the workplace.

āš ļø Risk Analysis

Key Uncertainties

Labour management risks regarding the availability of specialized doctors and nurses, and potential supply chain disruptions for medical equipment.

Geographic Concentration Risk

100% of revenue is concentrated in the Trichy, Tamil Nadu region, making it vulnerable to local economic or regulatory shifts.

Third Party Dependencies

Dependency on third-party vendors for medical equipment maintenance and pharmaceutical supplies.

Technology Obsolescence Risk

Managed through ISO 27001:2022 certification and regular facility and risk assessment audits.